Thema
Medicine
9
R
9
parp inhibitors
7
olaparib
4
ovarian cancer
3
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
2
brca
2
germline mutations
2
parp-inhibitor
2
prostate cancer
2
Acute Myeloid Leukemia
1
Acute leukemia
1
Combination therapies
1
Drug targets
1
Education
1
L
1
PARP inhibitor
1
Sports
1
anemia
1
antiangiogenic therapy
1
brca mutation
1
brca-associated breast cancer
1
brca1/2 gene
1
brca1/2 mutations
1
brca1/brca2 mutations
1
breast cancer
1
chemotherapy
1
clinical practice
1
disease control
1
drug therapy
1
germline mutation
1
healthy carriers of mutations
1
her2neu amplification
1
hereditary breast cancer
1
immunotherapy
1
lucy
1
maintenance therapy
1
metastatic breast cancer
1
metastatic castration-resistant prostate cancer
1
mutations in dna repair genes
1
next-generation sequencing
1
objective response
1
olympiad
1
parp inhibitor
1
pedigree
1
progression-free survival
1
real-world evidence (rwe)
1
somatic mutations
1
talazoparib
1
thrombocytopenia
1
mehr ...